Cheng-Ping Wang

Cheng-Ping Wang

Auto-generated profile, based on publicly available information

Cheng-Ping Wang

National Taiwan University Hospital

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

5 May 2016 in Chinese Journal of Cancer
Verified
Journal Article
Open access
PDF file
HWHai-Yun Wang
Hai-Yun Wang
YCYih-Leong Chang
Yih-Leong Chang
Ka Fai ToKa Fai To
Ka Fai To
JHJacqueline S. G. Hwang
Jacqueline S. G. Hwang
HMHAIQIANG MAI
HAIQIANG MAI
JSJian-Yong Shao
Jian-Yong Shao
The current World Health Organization (WHO) classification of nasopharyngeal carcinoma (NPC) conveys little prognostic information. This study aimed to propose an NPC histopathologic classification that can potentially be used to predict prognosis and treatment response. We initially developed a histopathologic classification based on the morphologic traits and cell differentiation of tumors of 2716 NPC patients who were identified at Sun Yat-sen University Cancer Center (SYSUCC) (training cohort). Then, the proposed classification was applied to 1702 patients (retrospective validation cohort) from hospitals outside SYSUCC and 1613 patients (prospective validation cohort) from SYSUCC. The efficacy of radiochemotherapy and radiotherapy modalities was compared between the proposed subtypes. We used Cox proportional hazards models to estimate hazard ratios (HRs) with 95% confidence intervals (CI) for overall survival (OS). The 5-year OS rates for all NPC patients who were diagnosed with epithelial carcinoma (EC; 3708 patients), mixed sarcomatoid-epithelial carcinoma (MSEC; 1247 patients), sarcomatoid carcinoma (SC; 823 patients), and squamous cell carcinoma (SCC; 253 patients) were 79.4%, 70.5%, 59.6%, and 42.6%, respectively (P < 0.001). In multivariate models, patients with MSEC had a shorter OS than patients with EC (HR = 1.44, 95% CI = 1.27–1.62), SC (HR = 2.00, 95% CI = 1.76–2.28), or SCC (HR = 4.23, 95% CI = 3.34–5.38). Radiochemotherapy significantly improved survival compared with radiotherapy alone for patients with EC (HR = 0.67, 95% CI = 0.56–0.80), MSEC (HR = 0.58, 95% CI = 0.49–0.75), and possibly for those with SCC (HR = 0.63; 95% CI = 0.40–0.98), but not for patients with SC (HR = 0.97, 95% CI = 0.74–1.28). The proposed classification offers more information for the prediction of NPC prognosis compared with the WHO classification and might be a valuable tool to guide treatment decisions for subtypes that are associated with a poor prognosis.

1 April 2004 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
CWCheng‐Ping Wang
Cheng‐Ping Wang
YCYih‐Leong Chang
Yih‐Leong Chang
TSTzung‐Shiahn Sheen
Tzung‐Shiahn Sheen

30 January 2013 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
TCTseng-Cheng Chen
Tseng-Cheng Chen
CWCheng-Ping Wang
Cheng-Ping Wang
JKJeng-Yuh Ko
Jeng-Yuh Ko
TYTsung-Lin Yang
Tsung-Lin Yang
CHChun-Wei Hsu
Chun-Wei Hsu
PLPei-Jen Lou
Pei-Jen Lou

1 March 2012 in European Journal of Radiology
Verified
Journal Article
Closed access
CWCheng-Ping Wang
Cheng-Ping Wang
TCTseng-Cheng Chen
Tseng-Cheng Chen
TYTsung-Lin Yang
Tsung-Lin Yang
CCChun-Nan Chen
Chun-Nan Chen
CLChin-Fon Lin
Chin-Fon Lin
JKJenq-Yuh Ko
Jenq-Yuh Ko

1 March 2009 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
YLYi-Chia Lee
Yi-Chia Lee
CWCheng-Ping Wang
Cheng-Ping Wang
CCChien-Chuan Chen
Chien-Chuan Chen
HCHan-Mo Chiu
Han-Mo Chiu
JKJenq-Yuh Ko
Jenq-Yuh Ko
Hsiu-Po WangHsiu-Po Wang
Hsiu-Po Wang